“Tralokinumab versus Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis with Hand Involvement: a Matching-Adjusted Indirect Comparison”, J of Skin, vol. 10, no. 2, p. s725, Mar. 2026, doi: 10.25251/24g02225.